Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Prostatype Genomics AB
AB
Active
Org 5567260285
Augustendalsvägen 20, 131 52
Nacka Strand
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2007 · 19 years old
5-9 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Prostatype Genomics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
1M
2022
1M
2023
0M
2024
EBITDA
SEK millions
0M
-10M
-19M
-29M
-39M
-16M
2020
-15M
+6%
2021
-27M
-80%
2022
-31M
-15%
2023
-28M
+10%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
684
10
683
1 356
199
Staff expenses
—
—
—
—
—
EBITDA
−15 765
−15 460
−26 786
−30 970
−28 130
Depreciation & amort.
−149
−88
−1 904
−1 875
−1 899
EBIT
−15 914
−15 548
−28 690
−32 845
−30 029
Net financials
−1 494
−81
−396
−2 356
−23 306
Profit before tax
−17 408
−15 630
−29 087
−34 559
−41 051
Tax
−0
−0
−0
−0
−0
Net profit
−17 408
−15 630
−29 087
−34 559
−41 051
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
33 663
40 203
30 950
55 584
49 126
Equity
28 290
35 906
26 151
31 196
41 150
Long-term debt
1 067
867
467
67
0
Short-term debt
4 306
3 430
4 333
24 321
7 975
Total debt
5 373
4 297
4 800
24 388
7 975
Financial ratios
5-year trend
EBITDA-margin
-14135.7%
This company
15.8%
Market median
-89566% vs market
2020
2024
Soliditetsgrad
83.8%
This company
38.2%
Market median
+119% vs market
2020
2024
Egenkapitalforrentning
-99.8%
This company
18.4%
Market median
-642% vs market
2020
2024
Nettoresultatgrad
-20628.6%
This company
8.1%
Market median
-254774% vs market
2020
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Gæld/egenkapital
0.19×
This company
0.62×
Market median
+69% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-12-31
View
PDF
More on Prostatype Genomics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
